MBL77 - AN OVERVIEW

In addition, several effectively proven adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their damaging outcome in sufferers addressed with VO. The only variable that remained predictive of a shorter progression-free survival During this cohort of individuals was TP53 aberrations.112 Eventually, the